Stem cell treatment for non-lacunar stroke after the first day
Part of Brain & nervous system, Heart & circulation clinical trials.
This early-phase study tests a stem cell treatment for certain types of stroke, focusing first on safety and the right dose. It may help doctors learn whether the treatment is safe and potentially beneficial when given soon after stroke begins.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be age 18 or older
- Have had an ischemic stroke that affects one side of the brain (not a “lacunar” stroke), confirmed on CT/MRI
- Be admitted to the stroke unit within 24 hours of stroke start, and enroll between 24 and 48 hours after stroke onset
- Have stroke severity at least moderate (NIHSS score 7 or higher, with arm/leg/hand weakness score 3 or higher)
- Be able to take part in a rehabilitation program and follow study visits
- Have no decompressive brain surgery planned or already done and be able to have MRI scans
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a patient's own stem cells can be safely injected into the brain to help recovery after a stroke. It is for people who had an ischemic stroke 6 months to 5 years ago and still have moderate to severe symptoms.
This study looks at how well early treatment works for people having their first stroke. It may help doctors understand what treatments help the most soon after a stroke starts.
This trial tests whether an investigational study drug can improve outcomes after an acute ischemic stroke (a stroke caused by blocked blood flow). You may be eligible if you are able to start treatment quickly after symptom onset and have a moderate stroke severity on a standard stroke exam.
This study tests a new treatment using exosomes (tiny particles from stem cells) given through a vein to people who recently had an ischemic stroke. It aims to see if this treatment is safe and helps improve recovery.
This trial tests an experimental treatment made from stem cells (exosomes) given within a week of a stroke, to see if it can help the brain recover. It is designed for people with moderate stroke symptoms who were otherwise healthy before the stroke.
This trial tests whether a special type of stem cell (from umbilical cord) can help people recover after a recent ischemic stroke. It aims to see if this treatment can improve movement and reduce disability.
Hear when a new Stroke trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.